124 related articles for article (PubMed ID: 8837316)
1. The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats.
Mysliwiec J; Azzadin A; Chabielska E; Takada A; Mysliwiec M; Buczko W
Thromb Res; 1996 Jul; 83(2):175-81. PubMed ID: 8837316
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine A affects serotonergic mechanisms in uremic rats.
Krygicz D; Azzadin A; Pawlak R; Małyszko JS; Pawlak D; Myśliwiec M; Buczko W
Pol J Pharmacol; 1996; 48(3):351-4. PubMed ID: 9112676
[TBL] [Abstract][Full Text] [Related]
3. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
4. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
Azzadin A; Małyszko J; Małyszko JS; Tankiewicz A; Myśliwiec M; Buczko W
Pol J Pharmacol; 2002; 54(5):469-73. PubMed ID: 12593533
[TBL] [Abstract][Full Text] [Related]
5. The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats.
Reis F; Tavares P; Fontes Ribeiro CA; Antunes F; Teixeira F
Thromb Res; 1999 Dec; 96(5):365-72. PubMed ID: 10605951
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
[No Abstract] [Full Text] [Related]
7. Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats.
Azzadin A; Mysliwiec J; Wollny T; Mysliwiec M; Buczko W
Thromb Res; 1995 Feb; 77(3):217-24. PubMed ID: 7740514
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation.
Kur F; Reichenspurner H; Meiser BM; Welz A; Fürst H; Müller C; Vogelmeier C; Schwaiblmaier M; Briegel J; Reichart B
Thorac Cardiovasc Surg; 1999 Jun; 47(3):174-8. PubMed ID: 10443520
[TBL] [Abstract][Full Text] [Related]
9. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.
Radermacher J; Meiners M; Bramlage C; Kliem V; Behrend M; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
Transpl Int; 1998; 11(1):3-10. PubMed ID: 9503547
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
Boctor FN
Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation is increased in cyclosporin A-induced hypertensive rats.
Reis F; Tavares P; Rito LC; Teixeira HM; Santos Dias JD; Ferrer-Antunes C; Mesquita JF; Teixeira F
J Cardiovasc Pharmacol; 2000 Jul; 36(1):56-64. PubMed ID: 10892661
[TBL] [Abstract][Full Text] [Related]
12. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
13. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.
Woo M; Przepiorka D; Ippoliti C; Warkentin D; Khouri I; Fritsche H; Körbling M
Bone Marrow Transplant; 1997 Dec; 20(12):1095-8. PubMed ID: 9466284
[TBL] [Abstract][Full Text] [Related]
14. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
16. The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy.
Burke GA; McGraw ME; MacIver AG
Pediatr Nephrol; 1999 Sep; 13(7):564-6. PubMed ID: 10460501
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
[TBL] [Abstract][Full Text] [Related]
18. Intestinal thrombotic microangiopathy induced by FK506 in rats.
Fujino M; Kim Y; Ito M
Bone Marrow Transplant; 2007 Mar; 39(6):367-72. PubMed ID: 17277791
[TBL] [Abstract][Full Text] [Related]
19. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient.
Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E
Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824
[No Abstract] [Full Text] [Related]
20. Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.
Randhawa PS; Tsamandas AC; Magnone M; Jordan M; Shapiro R; Starzl TE; Demetris AJ
Am J Surg Pathol; 1996 Mar; 20(3):306-12. PubMed ID: 8772784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
